Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

Clinical trial NCT04922554 · COMPLETED

Trial details

NCT number: NCT04922554
Sponsor: Paratek Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mycobacterium Infections, Nontuberculous Mycobacterium Abscessus Infection Nontuberculous Mycobacterial Lung Disease Nontuberculous Mycobacterial Pulmonary Infection

Start date: 2021-10-15
Primary completion: 2024-06-17
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.